Kallyope Inc.
Clinical trials sponsored by Kallyope Inc., explained in plain language.
-
Migraine drug tested for Long-Term safety in 1,000-Person trial
Symptom relief Not yet recruitingThis phase 3 study evaluates the long-term safety of elismetrep (K-304), an oral medication taken as needed for migraine attacks. About 1,000 adults who previously took elismetrep in an earlier trial will continue using it intermittently. Researchers will track side effects over …
Phase: PHASE3 • Sponsor: Kallyope Inc. • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
New migraine pill aims to stop pain in 2 hours – major trial underway
Symptom relief Not yet recruitingThis study tests a new drug, elismetrep, to see if it can quickly stop migraine pain and bothersome symptoms like nausea or light sensitivity. About 1800 adults with frequent migraines will receive either the drug or a placebo. The main goal is to measure how many people are pain…
Phase: PHASE3 • Sponsor: Kallyope Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC